Application of densitometry for determination of beta-adrenergic-blocking agents in pharmaceutical preparations

Journal of Planar Chromatography - Modern TLC

Volumn 18, Issue 104, 2005, Pages 308-313

  Krzek, Jan ^a   Kwiecień, Anna ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Beta blockers; Densitometry; Drug analysis; TLC determination

Indexed keywords

ABSORPTION; CHROMATOGRAPHIC ANALYSIS; DENSITOMETERS; DRUG PRODUCTS; METHANOL; SILICA GEL; THIN LAYER CHROMATOGRAPHY;

BETA-ADRENERGIC-BLOCKING AGENTS; DENSITOMETRY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; PHARMACEUTICAL PREPARATION;

AGENTS;

ACEBUTOLOL; ACECOR; AMMONIA; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOCARD; BISOHEXAL; BISOPROLOL; BISOPROLOL FUMARATE; CHLOROFORM; LABETALOL; METHANOL; METOPROLOL; NORMOCARD; OXPRENOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL;

ACCURACY; ARTICLE; CALCULATION; CONTROLLED STUDY; DENSITOMETRY; DRUG IDENTIFICATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; LINEAR SYSTEM; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SPECTRAL SENSITIVITY; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 24344478758     PISSN: 09334173     EISSN: None     Source Type: Journal    
DOI: 10.1556/JPC.18.2005.4.11     Document Type: Article

References (17)

1. D. Liszewska-Pfejfer and W. Kostowski, Leki beta-adrenolityczne w farmakoterapii, PZWL, Warsaw, 2000.
2. R. Gryglewski and E. Trabka-Kostka, Leki beta-adrenolityczne, PZWL, Warsaw, 1983.
3. C.J. Davies, J. Chromatogr. Biomed. Appl. 531 (1990) 131-180.
4. A. Zejc and M. Gorczyca, Chemia leków, PZWL, Warsaw, 1999.
5. R. Kaliszan, A. Nasal, and A. Buciński, Eur. J. Med. Chem. 29 (1994) 163-170.
6. R. Kaliszan, A. Nasal, and M. Turowski, Biomed. Chromatogr. 9 (1995) 211-215.
7. V. Martinez, M.I. Maguregui, R.M. Jimenez, and R.M. Alonzo, J. Pharm. Biomed. Anal. 23(2/3) 2000 459-468.
8. G. Lamprecht, T. Kreushofer, K. Stoschitzky, and W. Lindner, J. Chromatogr. B 740 (2000) 219-226.
9. V Andrisano, R. Gotti, A. Leoni, and V. Cavrini, J. Pharm. Biomed. Anal. 21 (1999) 851-857.
10. A. El-Gindy, A. Ashour L. Abel-Fattah, and M. Shabana, J. Pharm. Biomed. Anal. 24(4) (2001) 527-534.
11. H. Siren, M. Saarinen, and S. Hainari, J. Chromatogr. 632(1/2) (1993) 215-227.
12. R. Arias, R.M. Jimenez, R.M. Alonso, and M. Telez, J. Chromatogr. A 916 (1/2) 2001 297-304.
13. A.M. Tivert and A. Backman, J. Planar. Chromatogr. 6 (1993) 216-219.
14. Z. Pawlak and B.J. Clark, J. Pharm. Biomed. Anal. 10(5) 1992) 329-334.
15. A.P. Argekar and S.G. Powar, J. Pharm. Biomed. Anal. 21 (2000) 1137-1142.
16. Validation of Analytical Procedures: Methodology, ICH Harmonised Tripartite Guideline, 1996. www.nihs.go.jp/dig/ich/quality /q2b/q2bstep4.pdf
17. European Pharmacopoeia, 3rd edn, Strasbourg, 1997, and supplements 1999, 2000, 2001, 2002.